- Research works
- 85 ▲ 125% vs 2018-21
- Citations
- 1.1k 13.3 per fractional work
- Top-10% rate
- 5.5% all institutions 10.0%
- Open access
- 52% world 40%
- International
- 21% world 18%
Not ranked overall: Alembic Pharmaceuticals (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Alembic Pharmaceuticals (India) work in?
In 2022-now, 37% of research at Alembic Pharmaceuticals (India) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (35%), Biochemistry, Genetics and Molecular Biology (12%), Agricultural and Biological Sciences (9%). It does 1.7× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 21 fields, with their numbers
- Health Sciences1136.7%
- Medicine1034.7%
- Health Professions01.1%
- Dentistry00.7%
- Nursing00.3%
- Life Sciences929.7%
- Physical Sciences722.6%
- Engineering27.1%
- Environmental Science25.5%
- Materials Science14.0%
- Chemistry13.7%
- Computer Science12.0%
- Chemical Engineering00.3%
- Social Sciences311.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 15.9×. Every wedge is a field page.
All 21 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics15.93×2 works
- Immunology and Microbiology2.76×1 works
- Chemistry2.34×1 works
- Biochemistry, Genetics and Molecular Biology2.18×4 works
- Agricultural and Biological Sciences1.91×3 works
- Medicine1.81×10 works
- Dentistry1.38×0 works
- Materials Science1.14×1 works
- Environmental Science1.12×2 works
- Chemical Engineering0.80×0 works
- Decision Sciences0.69×0 works
- Nursing0.57×0 works
- Social Sciences0.57×2 works
- Psychology0.51×0 works
- Engineering0.47×2 works
- Health Professions0.41×0 works
- Neuroscience0.34×0 works
- Arts and Humanities0.30×0 works
- Computer Science0.26×1 works
- Business, Management and Accounting0.22×0 works
- Economics, Econometrics and Finance0.01×0 works
- Pharmacology, Toxicology and Pharmaceutics 15.9×
- Immunology and Microbiology 2.8×
- Chemistry 2.3×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Agricultural and Biological Sciences 1.9×
- Medicine 1.8×
- Dentistry 1.4×
- Materials Science 1.1×
- Environmental Science 1.1×
- Chemical Engineering 0.8×
- Decision Sciences 0.7×
- Nursing 0.6×
- Social Sciences 0.6×
- Psychology 0.5×
- Engineering 0.5×
- Health Professions 0.4×
- Neuroscience 0.3×
- Arts and Humanities 0.3×
- Computer Science 0.3×
- Business, Management and Accounting 0.2×
- Economics, Econometrics and Finance 0.0×
Who are the top researchers at Alembic Pharmaceuticals (India)?
Ranked on the quality score, M. R. S. Iyengar and Sanjay Jain lead among researchers whose main affiliation is Alembic Pharmaceuticals (India).
- 1
M. R. S. Iyengar
India · #3,290,694 worldwide 436 citations · 36 works
- 2
Sanjay Jain
India · #4,221,067 worldwide 13 citations · 21 works
Which keywords describe research at Alembic Pharmaceuticals (India)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Tumor Microenvironment, Inflammation, Breast Cancer, IL-6, STAT3, Nanoparticles and Phylogenetic Analysis.
- Epithelial-Mesenchymal Transition
- Antioxidant
- Phylogenetic Analysis
- IL-6
- Climate Change
- Tumor Microenvironment
- Inflammation
- Cancer
- Epidemiology
- Nanoparticles
- Breast Cancer
- STAT3
- Population Dynamics
- Biomedical Applications
- Genetic Diversity
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 15 words, with their numbers
- Cancer3▲ 6.5×9 topics
- Inflammation2▲ 3.9×12 topics
- Epidemiology2▲ 1.89×18 topics
- Tumor Microenvironment2▲ 14×3 topics
- Nanoparticles2▲ 4.2×7 topics
- Climate Change2▲ 1.82×6 topics
- Breast Cancer1▲ 18×7 topics
- IL-61▲ 205×1 topic
- STAT31▲ 205×1 topic
- Phylogenetic Analysis1▲ 13×2 topics
- Population Dynamics1▲ 16×3 topics
- Antioxidant1▲ 5.2×5 topics
- Biomedical Applications1▲ 2.8×6 topics
- Epithelial-Mesenchymal Transition1▲ 34×3 topics
- Genetic Diversity1▲ 7.7×2 topics
Which research topics does Alembic Pharmaceuticals (India) publish most on?
By volume in 2022-now: Cytokine Signaling Pathways and Interactions, Cancer Cells and Metastasis, Fish Biology and Ecology Studies and Pneumonia and Respiratory Infections.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cytokine Signaling Pathways and Interactions Oncology 1 works
- 2 Cancer Cells and Metastasis Oncology 1 works
- 3 Fish Biology and Ecology Studies Aquatic Science 1 works
- 4 Pneumonia and Respiratory Infections Epidemiology 1 works
- 5 Advanced Drug Delivery Systems Pharmaceutical Science 1 works
- 6 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
- 7 Amphibian and Reptile Biology Global and Planetary Change 0 works
- 8 Women's cancer prevention and management Public Health, Environmental and Occupational Health 0 works
- 9 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
- 10 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Alembic Pharmaceuticals (India)'s research output changed?
Output in 2022-2025 was 125% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Alembic Pharmaceuticals (India) as a percentage of every work published that year, 0.00015% in 2024.
Fractional works of Alembic Pharmaceuticals (India) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Vadodara
- Maharaja Sayajirao University of Baroda
- Sir Sayajirao General Hospital Medical College
- Manubhai Patel Dental College and Hospital
- Indian Institute of Information Technology Vadodara
- KM Shah Dental College and Hospital
- Suamandeep Vidyapeeth University
- Berry (India)
- Sheth M. L. Vaduwala Charitable Eye Hospital and Dr. Thakorbhai V. Patel Eye Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Alembic Pharmaceuticals (India). Posts are plain text and can be reported.